Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Invest. 2012 Feb;30(2):180-8. doi: 10.3109/07357907.2011.633294. Epub 2011 Dec 7.

Distinguishing non-small cell lung adenocarcinoma patients from squamous cell carcinoma patients and control individuals using serum profiling.

Author information

1
Department of Biochemistry & Molecular Biology, University of Oklahoma Health Science Center, University of Oklahoma, Oklahoma City, Oklahoma 73104, USA.

Abstract

Goals of this study were to analyze the ability of mass spectrometry serum profiling to distinguish non-small cell lung adenocarcinoma from squamous cell carcinoma patients and healthy controls. Sera were obtained from 19 adenocarcinoma patients, 24 squamous cell carcinoma patients, and 21 controls. Identifications of significant mass-to-charge ratio (m/z) peak differences between these groups were performed using t-tests. A "leave one out" cross-validation procedure yielded discriminatory lung adenocarcinoma versus squamous cell carcinoma p and ROC curve values of <.0001 and 0.92, respectively. Test sensitivity and specificity were 84% and 79%, respectively. This approach could aid in lung cancer diagnosis and sub-typing.

PMID:
22149138
DOI:
10.3109/07357907.2011.633294
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center